CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

News

Show search box
2013-01-14
 Janssen Pharmaceutica cooperates with Russian NewVac – the symptom of Russian pharmaceutic

Janssen Pharmaceutica cooperates with Russian NewVac – the symptom of Russian pharmaceutical market evolution

On January 7th NewVac, the subsidiary of ChemRar High Tech Center (a Russian non-governmental R&D center for life sciences), announced a co-license agreement with Janssen Pharmaceutica, a pharmaceutical company of Johnson & Johnson. According to the contract NewVacs receives the exclusive rights for... Read more
Tags pharma , russia
 Czech Republic participation in Nanotech 2012 as the only producer of inorganic nano-fiber

Czech Republic participation in Nanotech 2012 as the only producer of inorganic nano-fibers on the industrial scale

Nanotech is The World’s Largest Nanotechnology Exhibition and Conference, which is held every year in Japan – the global leader in the field of nanotechnology. On February 15th - 17th, Czech Republic participated with the 10 representative firms having their own national stand for the first time in t... Read more
Tags czech republic , events , nanotechnology
2013-01-08 to 2013-01-11
From renewable feedstock to butadiene - The next stage of Synthos and Global Bioenergies pa

From renewable feedstock to butadiene - The next stage of Synthos and Global Bioenergies partnership

In July 2011 Synthos, a Polish chemical company, one of the biggest manufacturers of rubber in Europe, and Global Bioenergies, a French company developing the sustainable way of olefins production, signed an agreement. Encouraged by the success of bio-sourced isobutene, Synthos entered a strategic pa... Read more
Tags biotechnology , poland , europe
Will Adamed win against cancers? Part II of the interview with Dr Jerzy Pieczykolan about 3

Will Adamed win against cancers? Part II of the interview with Dr Jerzy Pieczykolan about 3-CLA project

Adamed is a Polish pharmaceutical and biotech company focused on the next generation drug development and production. For over 25 years, the company has been providing pharmaceuticals to patients suffering from cardiology, pulmonology, gastroenterology, gynaecology, diseases of the central nervous sy... Read more
Tags biotechnology , poland , medicine , pharma , interview
 The largest biotech center in Eastern Europe in Vilnius already open

The largest biotech center in Eastern Europe in Vilnius already open

The Biotechpharma Research and Development Center was built and fully equipped in just 14 months and the investment claimed 56 mln Lt from which 38 mln Euro was obtained from European Structural Founds. It is claimed to be the most modern biotech center in the Eastern Europe and be competitive in co... Read more
Tags biotechnology , pharma , lithuania
Will Adamed win against cancers? Part III of the interview with Dr Jerzy Pieczykolan about

Will Adamed win against cancers? Part III of the interview with Dr Jerzy Pieczykolan about 3-CLA project

Adamed is a Polish pharmaceutical and biotech company focused on the next generation drug development and production. For over 25 years, the company has been providing pharmaceuticals to patients suffering from cardiology, pulmonology, gastroenterology, gynaecology, diseases of the central nervous sy... Read more
Tags bioforum , biotechnology , poland , pharma
Will Adamed Group win against cancers? Part I of the interview with Dr Jerzy Pieczykolan ab

Will Adamed Group win against cancers? Part I of the interview with Dr Jerzy Pieczykolan about 3-CLA project

Adamed is a Polish pharmaceutical and biotech company focused on the next generation drug development and production. For over 25 years, the company has been providing pharmaceuticals to patients suffering from cardiology, pulmonology, gastroenterology, gynaecology, diseases of the central nervous sy... Read more
Tags biotechnology , poland , medicine , pharma , interview
Cardiovascular diseases treatment in projects of Pharmahungary Group

Cardiovascular diseases treatment in projects of Pharmahungary Group

The Hungarian Pharmahungary Group is a strong company that provides preclinical and clinical R&D services. Their specialization is cardiovascular and metabolic diseases treatment. But, in fact, what did they achive to be proud of?... Read more
Tags pharma , hungary
2012-12-20
Which city is the best to live In? For several years Mercer Quality of Living Survey gives

Which city is the best to live In? For several years Mercer Quality of Living Survey gives the same answer: Vienna

Vienna is not only an economical and political center of Austria, but also one of the most important life science hubs in Europe. Especially in the field of biotechnology Vienna is the leading area in Austria and the most rapidly developing center of medical technology in the country.... Read more
Tags biotechnology , austria
 EU patents finally cheaper

EU patents finally cheaper

There is a great chance that Europe, after decades of impasse, will have a new unified patent law. Competitiveness Council and MEPs (Member of the European Parliament) finally reached a settlement and adopted the draft law, which will significantly reduce costs of new patents implementation. Nowadays... Read more
Tags europe
2012-12-05 to 2012-12-06
Supergenerics - Pharma’s freshmaker!

Supergenerics - Pharma’s freshmaker!

‘Boring’ white pills no longer do the trick from a marketing point of view. Furthermore governments and payers are looking at reducing the prices of the drugs as the way to contain costs. Additionally, margins of drugs are falling. Because of these two reasons there is a strong competition among com... Read more
Tags bioforum , events , pharma
Biotech and Pharma professionals getting together to overcome challenges and develop genuin

Biotech and Pharma professionals getting together to overcome challenges and develop genuine partnerships

In the aftermath of the global recession, the pharmaceutical and biotechnology industry has been facing new challenges. In the transforming environment - from healthcare reforms, the near-extinction of blockbuster drugs, to changing regulations - companies have little choice but to adapt their approa... Read more
Tags biotechnology , pharma
2012-11-28 to 2012-12-02
Biosan - Latvian Success Story

Biosan - Latvian Success Story

Biosan is a Latvian biotech company producing laboratory equipment that competes with the world leaders. The company’s offer is amazingly rich, starting from shakers, vortexes, PCR-boxes, to end with the line of instruments for DNA/RNA analyses. Biosan cares about its clients, paying a lot of attenti... Read more
Tags bioforum , biotechnology , interview , latvia
Prix Galien - first time in Poland!

Prix Galien - first time in Poland!

The first edition of prestigious Prix Galien Poland 2012 contest was closed on the 20th November of 2012. The awards are being given to the most groundbreaking and innovative solutions in the field of medicine and pharma for more than 40 years. Five gold medals were given away during the glamorous ce... Read more
Tags poland , medicine , events , pharma
Russia corners the market of clinical trials

Russia corners the market of clinical trials

Lately, increased activity in clinical trials could be observed in the Russian market. Only in the second quarter of 2012 275 trials were approved, which is a 44% jump from the same period in 2011. According to Vladimir Putin words, Russia aims for being a super power in the sector of biomedicine and... Read more
Tags biotechnology , pharma , russia
Mabion obtains positive FDA-EMA report

Mabion obtains positive FDA-EMA report

Mabion SA — Polish biotechnological company, which develops and introduces the latest generation of drugs based on humanized monoclonal antibodies to the market, has received a document informing about termination of Scientific Advice joint procedure conducted by the European Medicines Agency and t... Read more
Tags biotechnology , poland , pharma , interview
2012-11-13
Patents of those pharmaceutical drugs expire in 2013

Patents of those pharmaceutical drugs expire in 2013

In 2013, many drugs lose their patents claims, which will result in the confusion on the market of drugmakers. According to EvaluatPharma estimations, pharmaceutical companies will not only lose the market exclusivity on their top selling drug, but also suffer from tremendous decrease of their income... Read more
Tags pharma
2012-11-08
BIOMAX SA - receives a positive assessment of the project financing application

BIOMAX SA - receives a positive assessment of the project financing application

The Polish biotech company BIOMAX SA - received information from the National Center for Research and Development about a positive assessment of the proposal for funding of the company's project: "Development of innovative manufacturing technology of a new generation of cosmetics and dietary suppleme... Read more
Tags biotechnology , poland , interview
2012-10-29
The Top CEE biotech licensing opportunities

The Top CEE biotech licensing opportunities

Pharmaceutical companies are looking for sources of new products and technologies in biotechnology industry to extend the existing pipeline. The major objectives of pharmaceutical and biotechnology businesses are to be the first on the market with new therapeutic entities, achieve maximum market pene... Read more
Tags bioforum , biotechnology , pharma
2012-10-18
Penta sells Alpha Medical laboratories

Penta sells Alpha Medical laboratories

Penta Investments, the Central European investment group, has signed an agreement to sell 100% stake in Alpha medical a.s. and Alpha medical Polska Sp. z o.o. to Mid Europa Partners. The transaction includes the whole Alpha Medical group and its assets in the Czech Republic, Slovakia and Poland. Alph... Read more
Tags poland , czech republic , europe , slovakia